Apyx Medical Statistics
Total Valuation
Apyx Medical has a market cap or net worth of $34.25 million. The enterprise value is $41.27 million.
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, before market open.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Apyx Medical has 37.79 million shares outstanding. The number of shares has increased by 2.66% in one year.
| Current Share Class | 37.79M |
| Shares Outstanding | 37.79M |
| Shares Change (YoY) | +2.66% |
| Shares Change (QoQ) | +10.31% |
| Owned by Insiders (%) | 14.56% |
| Owned by Institutions (%) | 25.07% |
| Float | 29.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.70 |
| Forward PS | 0.71 |
| PB Ratio | 2.51 |
| P/TBV Ratio | 2.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.86 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.26, with a Debt / Equity ratio of 2.70.
| Current Ratio | 5.26 |
| Quick Ratio | 4.41 |
| Debt / Equity | 2.70 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.19 |
Financial Efficiency
Return on equity (ROE) is -114.21% and return on invested capital (ROIC) is -19.88%.
| Return on Equity (ROE) | -114.21% |
| Return on Assets (ROA) | -16.35% |
| Return on Invested Capital (ROIC) | -19.88% |
| Return on Capital Employed (ROCE) | -34.82% |
| Revenue Per Employee | $218,645 |
| Profits Per Employee | -$106,650 |
| Employee Count | 220 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 2.14 |
Taxes
In the past 12 months, Apyx Medical has paid $252,000 in taxes.
| Income Tax | 252,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.09% in the last 52 weeks. The beta is 0.92, so Apyx Medical's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | -28.09% |
| 50-Day Moving Average | 1.20 |
| 200-Day Moving Average | 1.32 |
| Relative Strength Index (RSI) | 38.57 |
| Average Volume (20 Days) | 70,039 |
Short Selling Information
The latest short interest is 144,625, so 0.38% of the outstanding shares have been sold short.
| Short Interest | 144,625 |
| Short Previous Month | 125,316 |
| Short % of Shares Out | 0.38% |
| Short % of Float | 0.50% |
| Short Ratio (days to cover) | 2.70 |
Income Statement
In the last 12 months, Apyx Medical had revenue of $48.10 million and -$23.46 million in losses. Loss per share was -$0.66.
| Revenue | 48.10M |
| Gross Profit | 29.36M |
| Operating Income | -18.85M |
| Pretax Income | -28.50M |
| Net Income | -23.46M |
| EBITDA | -18.25M |
| EBIT | -18.85M |
| Loss Per Share | -$0.66 |
Full Income StatementBalance Sheet
The company has $31.74 million in cash and $38.76 million in debt, giving a net cash position of -$7.02 million or -$0.19 per share.
| Cash & Cash Equivalents | 31.74M |
| Total Debt | 38.76M |
| Net Cash | -7.02M |
| Net Cash Per Share | -$0.19 |
| Equity (Book Value) | 14.34M |
| Book Value Per Share | 0.38 |
| Working Capital | 45.72M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$18.05 million and capital expenditures -$722,000, giving a free cash flow of -$18.77 million.
| Operating Cash Flow | -18.05M |
| Capital Expenditures | -722,000 |
| Free Cash Flow | -18.77M |
| FCF Per Share | -$0.50 |
Full Cash Flow StatementMargins
Gross margin is 61.04%, with operating and profit margins of -39.18% and -48.78%.
| Gross Margin | 61.04% |
| Operating Margin | -39.18% |
| Pretax Margin | -48.45% |
| Profit Margin | -48.78% |
| EBITDA Margin | -37.93% |
| EBIT Margin | -39.18% |
| FCF Margin | n/a |